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Abstract
Despite accumulating evidence that procedural pain experienced by newborn infants may have acute
and even long-term detrimental effects on their subsequent behaviour and neurological outcome,
pain control and prevention remain controversial issues. Our aim was to develop guidelines based on
evidence and clinical practice for preventing and controlling neonatal procedural pain in the light of
the evidence-based recommendations contained in the SIGN classiﬁcation. A panel of expert
neonatologists used systematic review, data synthesis and open discussion to reach a consensus on
the level of evidence supported by the literature or customs in clinical practice and to describe a
global analgesic management, considering pharmacological, non-pharmacological, behavioural and
environmental measures for each invasive procedure. There is strong evidence to support some
analgesic measures, e.g. sucrose or breast milk for minor invasive procedures, and combinations of
drugs for tracheal intubation. Many other pain control measures used during chest tube placement
and removal, screening and treatment for ROP, or for postoperative pain, are still based not on
evidence, but on good practice or expert opinions.
Conclusion: These guidelines should help improving the health care professional’s awareness of the need to
adequately manage procedural pain in neonates, based on the strongest evidence currently available.
INTRODUCTION
Scientific research in recent years has continued to confirm
that neonates, especially when preterm, are more sensitive
to nociceptive stimuli than older children. Neonates are ca-
pable of mounting robust physiological, behavioural, hor-
monal and metabolic responses to such stimuli, responses
that can have adverse short- and long-term effects (1,2).
Several lines of evidence suggest that early and repeated
exposure to painful stimuli during a period fundamental to
nervous system development leads to persistent behavioural
changes and a smaller volume of the sensory areas of the
brain in ex-preterm infants (3,4).
The use of pain control for neonates undergoing painful
procedures is still limited, however. According to re-
cent reports, neonates at the Intensive Care Unit (NICU)
experience a mean 16 painful procedures a day, most of
which arestill performedwithouteffectivepain controlmea-
sures, as demonstrated by recent surveys (5,6).
The strength of existing evidence is crucial to the quality of
pain management. We report here on the clinical guidelines
developed by a panel of expert neonatologists who reached a
consensus on the recommendationsafter critically reviewing
the latest evidence in 2008.
The present guidelines should help clinicians to choose
the most effective and safe pain control measures based on
current knowledge. Adequate pain prevention and manage-
ment should be an essential part of standard health care at
the NICU, and recognizing and assessing sources of pain
should be routine in the day-to-day practice of physicians
and nurses taking care of the newborn.
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Table 1 Grades of recommendation and levels of evidence
Grade of recommen-
dation
Level of evidence
A At least one good-quality meta-analysis of randomized controlled trials (RCTs) or a sufﬁciently powered good-quality RCT with a very
low risk of bias, directly applicable to the target population
B A body of evidence including good-quality systematic reviews of case–control or cohort studies directly applicable to the target
population, or good-quality case–control or cohort studies with a very low risk of confounders or bias and a high probability of the
relationship being causal. Evidence extrapolated from good-quality meta-analyses, systematic reviews of RCTs or RCTs with a very
low or low risk of bias
C A body of evidence including well-conducted case–control or cohort studies with a low risk of confounders or bias and a moderate
probability of the relationship not being causal, directly applicable to the target population and demonstrating overall consistency of
results, or evidence extrapolated from good-quality systematic reviews of case–control or cohort studies, or good-quality case–control
or cohort studies
D Non-analytical studies, e.g. case reports, case series or evidence extrapolated from well-conducted case–control or cohort studies with a
very low risk of bias
Good practice
points
Recommended practice, based on the clinical experience of the group that developed the guidelines
Modiﬁed from the SIGN Guidelines Developer’s Handbook 2008.
METHODS
These guidelines were produced by the Pain Study Group
of the Italian Society of Neonatology at four meetings held
between June 2007 and January 2008. Each panel member
systematically reviewed the literature on a given invasive
procedure, evaluating the quality of the data and summa-
rizing the reported pharmacological, non-pharmacological,
behavioural and environmental pain control measures in a
practical format.
To identify and analyse all available publications on
neonatal pain, the Medline (via PubMed), EMBASE and
CINHAL databases were searched using pain, stress, no-
ciception, analgesia, sedation, anaesthesia and premedica-
tion, infant, newborn and premature as the key words, and
the Cochrane Library was checked for critical reviews. The
most significant results were presented at meetings of the
Study Group experts and discussed until the most appropri-
ate guidelines for each specific procedure were established,
based on the strongest evidence drawn from recently pub-
lished data and/or prevailing clinical practice at NICUs. The
method proposed by the Scottish Intercollegiate Guidelines
Network (SIGN) was used to draft these guidelines, award-
ing levels of evidence and grades of recommendation based
on the SIGN classification (7) (Table 1). The guidelines
were then submitted to critical review by independent pro-
fessionals operating in various disciplines (paediatricians,
anaesthesiologists, pharmacologists, psychologists, nurses)
and parents, who also applied an appraisal tool (AGREE)
to assess the quality of the clinical guidelines (8). The final
draft of the document was approved by the board of the
Italian Society of Neonatology in December 2007.
Safety considerations
Potential problems deriving from the use of these guidelines
relate to the possible side effects of drugs. Knowledge of the
pharmacology and pharmacodynamics of the drugs used,
which is not within the scope of this document, is essen-
tial. Respiratory depression, apnoea leading to bradycardia
and desaturation, partial airway obstruction and hypersali-
vation are the most important side effects of analgesic drugs.
However, it is important to emphasize that analgesia and
sedation, especially in neonates, should generally be admin-
istered by experts capable of immediately recognising and
appropriately treating any cardiorespiratory complications.
It is therefore important that emergency materials and drugs
are always available and readily accessible when stronger
drugs are used for analgesia and sedation.
Implementing these guidelines would not incur any addi-
tional cost because the drugs involved are already in use at
NICUs.
Editorial independence
These guidelines were developed with no outside funding
and the experts on the panel have no conflict of interest
with the pharmaceutical industry.
RESULTS
General principles
• Environmental, behavioural and non-pharmacological
comfort measures are recommended for each procedure,
e.g. the use of a pacifier with sucrose combined with dis-
traction techniques (Table 2). The pharmacological op-
tions used in combination with these measures can have
additive or synergic effects in controlling procedural pain
and stress.
• For planned procedures, such as blood sampling or cre-
ating a vascular access, the optimal baseline state of quiet
wakefulness should be obtained before starting the pro-
cedure.
• If possible, do not interrupt sleep; plan the procedure
far from mealtimes and from any other painful invasive
procedures to allow for recovery.
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Table 2 Environmental, behavioural and non-pharmacological pain control strategies in newborn
Author Heel
lancing
Veni-
puncture
Other
Sucrose: in doses from 0.012 to 0.12 g. 12–24% at a dose of 0.2–0.3 mL
orally 2 min before the procedure in preterm infants and 1–2 mL in term
infants.
Stevens B et al. Cochrane
Rev. 2004
AA –
Expressed human milk or breastfeeding Shah VS et al. Cochrane
Rev. 2006
AA –
Glucose solution: dose range 1–2 mL of 10–33% glucose Skogsdal Y et al.1997
Gradin M et al. 2004
Eriksson M et al.1999
Carbajal R et al. 1999
Carbajal R et al. 1999
CB –
Non-nutritive sucking (NNS): i.e. placing a paciﬁer in an infant’s mouth to
promote sucking behaviour with no breast or formula milk to provide
nourishment
Field T et al. 1984 Shiao
Y et al. 1997 Stevens B
et al. 1999 Bellieni CV
et al. 2001 Corbo MG
et al. 2000
B– –
Music therapy: music with intrauterine sounds or instrumental music in
association with NNS
Bo and Callaghan 2000
Butt and Kisilevsky
2000
D– –
Facilitated tucking: holding the arms and legs in a ﬂexed position Corff KE et al.1995
Axelin A. et al. 2006
Ward and Larson et al.
2004
C – Endotracheal
suctioning or routine
care C
Swaddling: wrapping the neonate in a sheet/blanket Fearon et al. 1997 Huang
et al. 2004
Prasopkittikun and
Tilokskulchai 2003
VanSleuwen BE et al.
2007
C– –
Maternal touching and holding: cradling the baby in the mother’s arms Prasopkittikun and
Tilokskulchai 2003
D– –
Kangaroo care or Kangaroo mother care: the neonate is taken out of the
incubator and laid on the mother’s or father’s bare skin (skin-to-skin
contact)
Gray L et al. 2000;
Johnston C et al. 2003
and 2008
Ludington-Hoe et al.
2005 Feber Sg et al.
2008
B– -
Positioning: laying the neonate supine; the evidence of its utility remains
inconclusive
Stevens B et al. 1999
Prasopkittikun and
Tilokskulchai 2003
Grunau R et al. 2004
–– –
Individualized developmental care, e.g. limiting environmental stimuli, lateral
positioning, using supportive bedding, monitoring behavioural clues,
respecting circadian rhythms
Sizun J et al. 2002 – – C
Olfactory stimulation: vanillin aroma Goubet et al. 2003 – C
Sensorial saturation: multiple sensorial stimulation at orogustatory, auditory,
olfactory and tactile level
Bellieni et al. 2001 B –
Environmental care: controlling/reducing light and noise Blackburn 1996, Franck
1998, Brandon 2002,
Anand 2001, Menon
1998, Sauve 1995,
AAP 1997
–– D
Parental presence during medical procedures Axelin A 2006 – – D
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• Conduct the procedure in a calm and relaxing environ-
ment, reducing noxious stimuli (light and noise) as much
as possible.
• During the procedure, the neonate should preferably be
contained in warm sheets and accompanied during and
after the procedure.
• Monitoring pain and stress as the fifth vital sign during
ongoing analgesia or invasive procedures with scales vali-
dated for infants may facilitate the fine tuning of analgesic
measures and improve awareness of how the newborn
feels.
• Attheendoftheprocedure,continuetomonitorthephys-
iological parameters until they return to the baseline state.
• Plan no other invasive procedures for at least 2 h after the
procedure.
Heel lancing
Environmental measures
• It is preferable to use venipuncture rather than heel lanc-
ing in term neonates and heavier premature infants, since
it is less painful and more effective in expert hands [A]
(9).
• It is not useful to warm the heel prior to lancing to facili-
tate blood flow to the area [C] (10,11).
• Use techniques to distract the neonate and provide stimuli
to stop pain transmission to the cerebral cortex, such as
sensorial saturation (a technique consisting in the mother
or nurse massaging and talking to the baby while admin-
istering oral glucose before the puncture) [B] (12).
• Consider involving the mother in procedures whenever
possible, using skin-to-skin contact or breastfeeding dur-
ing non-routine sampling [B] (13,14). The efficacy of
breastfeeding during multiple painful procedures has not
been documented (15).
• Use an automatic lancet of the Tenderfoot variety rather
than a manual lancet [B] (16,17).
• Do not squeeze the heel, which must be well perfused and
squeezing is itself a cause of pointless pain [D] (18).
Non-pharmacological measures
• Use sucrose and non-nutritive sucking (NNS) or human
milk [A] (15,19).
• The use of oral sucrose alone has recently proved ineffec-
tive in the case of repeated heel lances in term infants in
the first 2 days of life [B] (20).
• Alternatively, use a glucose solution [C] (21,22).
• The use of less-concentrated solutions is recommended in
premature infants because solutions with higher concen-
trations of sucrose/glucose (24–33%) have a high osmo-
larity, up to 1000 mOsm [D] (23).
• The use of NNS seems to have a synergic effect with the
sweet taste and is recommended, whenever possible [B]
(22,24).
• The use of multiple doses for a given procedure (2 min
before, immediately before and 2 min after heel lancing)
seems more effective than a single dose [B] (25).
• The long-term safety of multiple doses of oral sucrose has
not been demonstrated [A] (26).
Pharmacological measures
• The use of EMLA cream is not recommended as it is
ineffective for heel lancing pain [B] (27).
• Pre-emptive analgesia with paracetamol before the pro-
cedure is not recommended as it is ineffective [A] (28).
Venipuncture, arterial puncture and percutaneous
central venous catheter insertion
Environmental measures
Adopt all the environmental measures recommended for
heel lancing. Choose a smaller gauge trocar cannula of 24–
26 G, wherever possible. (This is what the SIGN calls a good
practice point [GPP]).
Non-pharmacological measures
Using sucrose and NNS or human milk [A] (15,19) seems
to be more effective than EMLA [C] (29).
Local pharmacological measures
• If it is possible to plan the procedure, apply EMLA cream
60 min beforehand with an occlusive bandage that does
not adhere to the skin (to avoid incurring pain on its
removal) [B] (27).
• During the application, check for any local reactions (hy-
peraemia, flushing, areas of cutaneous vasoconstriction)
that may occur when a local anaesthetic is applied [D]
(30).
• If available, anaesthetics with a faster onset of action
(30 min) should be used (liposomal lidocaine 4% cream)
[C] (31), while preparations such as tetracaine gel 4% are
not to be recommended because they are ineffective in
neonates [A] (32).
Systemic pharmacological measures
The use of systemic opiate-based analgesia is to be rec-
ommended in some situations. In intubated and ventilated
neonates, administer a slow i.v. bolus of opiates before the
procedure, as necessary [D] (18).
Intramuscular or subcutaneous injection
Environmental measures
It is preferable to administer drugs intravenously wherever
possible [GPP].
Adopt all the environmental measures mentioned in the
heel lancing section. Choose a smaller gauge needle wher-
ever possible [GPP].
Local pharmacological measures
Apply EMLA cream (0.5–1 g) 60 min before the procedure
[B] (33).
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Central venous catheter insertion by surgical cut-down
Non-pharmacological measures
Use sucrose and NNS or human milk during the preparatory
phase whenever possible [GPP] (18,19,34,35).
Local pharmacological measures
Apply EMLA cream 60 min before the procedure [C] (27)
or proceed directly with the subcutaneous infiltration of li-
docaine 1% at a dosage of 2–4 mg/kg buffered with sodium
bicarbonate (NaCHO3 8,4%) in 1:10 dilution [D] (35). The
buffered solution can reduce the pain of the local infiltration
(36).
Systemic pharmacological measures
• Sedation: administer a slow i.v. bolus of fentanyl [D]
(18,34,35) and midazolam, as necessary [GPP], or an i.v.
bolus of ketamine [GPP].
• Closely monitor the patient and anticipate any need for
ventilatory and circulatory support in the event of respi-
ratory depression [GPP].
• General anaesthesia: administer an i.v. bolus of fentanyl
and a muscle relaxant [GPP] (Table 3).
Tracheal intubation
Many different approaches are reported and a great variety
of drugs are used, alone or in combination, as premedica-
tion for elective intubation in neonates (37). Combinations
of opiate and muscle relaxant [B] (38–42) and remifentanil
and midazolam [B] (43) or propofol [B] (44), thiopental [B]
(45) and ketamine [D] (18) have been proposed. Using ap-
propriate analgesia and sedation during tracheal intubation
facilitates the procedure (fewer attempts and shorter times),
reducing potentially harmful physiological fluctuations and
pain [A] (37). In nasal intubation, small doses (0.3 mL/kg)
of lidocaine gel 2% may be useful [D] (46) (Table 4).
Lumbar puncture
Environmental measures
Whichever position is chosen (on the side, sitting in the
crib or on the nurse’s or mother’s arm), avoid any extreme
flexion of the neck and knees towards the chest because
this can cause significant hypoxemia, especially in critical
patients (47), as well as carrying a risk of vertebral fractures
[D] (48).
It is advisable to perform LP with a G24 Sprotte atrau-
matic needle, as it separates the fibres of the yellow ligament
withoutsevering them,and earlystylet removalimprovesthe
success rates [C] (49).
This avoids post-LP fluid exudation and the risk of sec-
ondary headache and the, albeit rare, onset of epidermoid
tumours in the spinal canal, reported after the use of butter-
fly or other spring needles without stylets [D] (50,51).
Non-pharmacological measures
Use sucrose and NNS or human milk [GPP] (15,18,19).
Local pharmacological measures
Apply EMLA cream to the puncture site 60 min before the
procedure [A] (52).
The use of other local anaesthetics, such as subcutaneous
lidocaine infiltration, is not recommended as a front-line
anaesthetic measure [C] (53,54), and we have no reports on
its use for deeper anaesthesia after EMLA.
Systemic pharmacological measures
The use of systemic analgesia and sedation with a slow
i.v. opiate bolus can be recommended in some cases if the
neonate is intubated. If term infants are not intubated, a
bolus of midazolam can be suggested if the infant is partic-
ularly restless, monitoring the vital signs (especially blood
pressure). After the procedure, keep the neonate supine,
continue with pain control measures and monitor the phys-
ical parameters until they return to the baseline state [GPP].
Consider using paracetamol for the treatment of headache
following subarachnoid puncture [D] (50).
Chest tube insertion
Non-pharmacological measures
Apply appropriate behavioural pain control measures [GPP]
(15,18,19,34,35).
Local pharmacological measures
If the procedure is not urgent, apply EMLA cream to the
puncture site [GPP]. If it is urgent, proceed directly with
subcutaneous lidocaine 1% infiltration [D] (18,34,35).
Systemic pharmacological measures
In intubated and ventilated neonates, administer a slow i.v.
opiate bolus [D] (18,34,35). In non-intubated neonates, con-
sider a bolus of ketamine, except for VLBWI, but anticipate
the need for intubation and ventilation in neonates breath-
ing spontaneously [D] (18,35). After the procedure, consider
the use of bolus or continuous venous infusions of opiates,
monitoring the pain scale [D] (18).
Chest tube removal
Non-pharmacological measures
Apply appropriate behavioural pain control measures [GPP]
(15,18,19,34,35).
Local pharmacological measures
Apply EMLA cream to the site of insertion [D] (55).
Systemic pharmacological measures
Consider a slow i.v. opiate bolus [GPP].
Screening for ROP
Non-pharmacological and environmental measures
Perform the screening procedure away from meals [GPP].
Use appropriate behavioural pain control measures and
sucrose and NNS [A] (56) or human milk [GPP] (15,19).
Conduct the ophthalmoscopy without using the ble-
pharostate, the positioning of which causes pain [C] (57).
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Table 3 Analgesic and anaesthetic drugs used in newborn
Drug Dose Safety considerations
Local anaesthetic
EMLA lidocaine–prilocaine 5% cream 0.5–1 g under non-adhesive occlusive dressing 60 min
before procedure
Check for any local reactions (hyperaemia,
ﬂushing, vaso-constriction) every 15 min
Liposomal lidocaine 4% cream 1 g under occlusive dressing 30 min before procedure
Lidocaine 1% 2–4 mg/kg buffered with sodium bicarbonate 1:10 Maximum dosage 5 mg/kg
Oxybuprocaine 0.4% and tetracaine
1% eye drops
1 drop per eye
Systemic analgesic Bolus dose Infusion dose
Morphine 50–100 mcg/kg i.v. in 60 min 10–40 mcg/kg/h
Fentanyl 0.5–3 mcg/kg i.v. in 30 min 0.5–3 mcg/kg/h
Acetaminophen or paracetamol 10–15 mg/kg i.v. in 15 min every 6–8 h (i.v.–oral)
General anaesthetic
Ketamine 0.5–2 mg/kg i.v. 0.5–1 mg/kg/h
Thiopental 2–6 mg/kg i.v.
Propofol 2.5 mg/kg 0.5–4 mg/kg/h
Muscle relaxants
Vecuronium 0.1 mg/kg i.v. 0.05–0.1 mg/kg/h
Mivacurium 0.2–0.3 mg/kg i.v.
Epidural anaesthetic
Bupivacaine 0.08–0.1% 0.25 mg/kg/h for max 24–36 h
Ropivacaine 0.9 mg/kg 0.2 mg/kg/h
Levobupivacaine 0.25% 2.5 mg/kg 0.25–0.75 mg/kg/h
Table 4 Drug associations for neonatal tracheal intubation
Drugs Grade of recommen-
dation
Combined i.v. infusions of atropine, an opiate and a muscle relaxant
Atropine 20 mcg/kg over 1 min + fentanyl 2 mcg/kg over 5 min + mivacurium 200 mcg/kg in rapid infusion B
Atropine 20 mcg/kg over 1 min + mivacurium 200 mcg/kg over 15–30 sec + fentanyl 5 mcg/kg over 1 min C
Atropine 20 mcg/kg over 1 min + fentanyl 3–4 mcg/kg over 5 min + suxamethonium 2 mg/kg in rapid infusion C
Morphine 100 mcg/kg + atropine 10 mcg/kg + suxamethonium 1 mg/kg B
Propofol 2.5 mg/kg i.v. in a rapid bolus (max 2 doses) B
Thiopental 6 mg/kg (2.5% solution) i.v. bolus over 1 min B
Remifentanil 1 mcg/kg over 1 min + midazolam 200 mcg/kg B
Ketamine 1 mg/kg i.v.+ atropine 20 mcg/kg D
Pharmacological measures
In the case of RetCam screening, apply local anaesthe-
sia with oxybuprocaine 0.4% or tetracaine 1% eye drops
and consider a slow i.v. opiate bolus or ketamine [D]
(57,58).
Laser therapy for ROP
Non-pharmacological measures
During preparations for the procedure, adopt appropriate
behavioural pain control measures [GPP] (15–19).
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Pharmacological measures
Ingeneral,combinealocal anaestheticwithageneral anaes-
thesia, administering a slow i.v. opiate bolus in association
with a muscle relaxant before intubation, or combine local
anaesthesia with sedation using low doses of opiates com-
bined with midazolam or ketamine, supporting the airways
with a positive pressure [D] (58). Nasopharyngeal prongs or
a laryngeal mask are a valid alternative to ventilatory sup-
port during brief measures if the neonate has not already
been intubated [D] (59). At the end of the procedure, ar-
range for postoperative analgesia for the first 24–48 h [D]
(18).
CONCLUSION
These guidelines on analgesia and sedation in neonates un-
dergoing invasive procedures should help improving the
health care professional’s awareness of the need to ade-
quately manage procedural pain in neonates, based on the
strongest evidence currently available. There is a large body
of evidence to support the utility of sucrose and NNS for
pain prevention during heel lancing and venipuncture, but
it is not clear whether multiple doses of sucrose are safe. The
role of breastfeeding or breast milk for pain control has also
been documented in the last few years. NNS and sensorial
saturation are other recommended techniques.
In the case of tracheal intubation, several studies have
demonstrated the efficacy of various drug combinations
comprising an analgesic (usually an opiate) and a muscle
relaxant in reducing pain and facilitating the procedure,
though the superiority of any given combination remains to
be established. Many other analgesics are commonly used
in practice, e.g. for chest tube placement and removal, lum-
bar puncture, screening for ROP and laser therapy, but their
usage is not evidence based.
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